NRIX Nurix Therapeutics announces hsr clearance of global collaboration with Roche to Co-develop and Co-commercialize potential best-in-clas
NRIX Nurix Therapeutics announces hsr clearance of global collaboration with Roche to Co-develop and Co-commercialize potential best-in-class btk degrader bexobrutideg across malignant hematology, immunology and neurology